Continuous Glucose Monitoring Market
The Global Continuous Glucose Monitoring Market is valued at US$ YY Mn in 2018 and is expected to grow at a CAGR of 22.0% over the forecast period to reach US$ YY Mn by 2029.
The rising incidence of diabetes is one of the key factors fueling the global continuous glucose monitoring market.
Download free sample @ https://bit.ly/3CZFg3I
Market Dynamics
The increasing pipeline devices of continuous glucose monitoring is one of the key factors driving the global continuous glucose monitoring market.
In January 2018, WaveForm Technologies Inc., a developer of novel products for diabetes care, today announced it had completed four human clinical trials for its proprietary continuous glucose monitoring (“CGM”) system. The WaveForm CGM system provides rapid, easy and painless on-body sensor insertion, limited interferences, rapid warm-up time, more frequent glucose measurements, limited calibrations, and the potential for 14 days and longer usage.
The rising incidence of diabetes is one of the key factors fueling the global continuous glucose monitoring market.
Market Segmentation
- By Component
- By Region
By Component – Transmitter
Transmitters of the continuous glucose monitoring system are constantly being improved design-wise and its life-cycle. This is mainly due to the new sensors being launched and approved by the FDA.
Most of the recent transmitters have become more user-friendly with their additional feature.
Medtronics Guardian Connect Smart CGM has a Bluetooth transmitter.
View full report @ https://bit.ly/3KWnb9k
Geographical Analysis report
The increase in cases of diabetes is one of the key factors driving the North American continuous glucose monitoring market, and there is an increase in regulatory approval for continuous glucose monitoring components is one of the factors fueling the global continuous glucose monitoring market.
For instance, on 21, June 2018, Senseonics Holdings, Inc. has received Premarket Approval (PMA) from U.S. Food and Drug Administration to market Eversense Continuous Glucose Monitoring (CGM) System to people with diabetes in the United States. The system is the first and only CGM system to feature an implantable glucose sensor and provide long-term continuous monitoring for up to three months.
Trending Topic’s
Automated External Defibrillator Market
Media Contact
Company Name: DataM Intelligence
Contact Person: Sai
Email: Send Email
Phone: +1 877 441 4866
Country: United States
Website: https://www.datamintelligence.com/research-report/continuous-glucose-monitoring-market